Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn various ways to cut costs on a limited budget. Make smarter financial choices and save effectively.
21,750 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
Cardano is accelerating governance upgrades to win enterprise adoption in a stricter regulatory era. The network rati...
Rival AI employees have filed an amicus brief backing Anthropic in a Pentagon-led dispute over a supply-chain risk de...
Oracle delivered a standout quarter, signaling AI investments and data-center expansion can pay off. The company rais...
Two of the nation's largest reverse mortgage lenders have moved to dismiss a California federal lawsuit accusing dece...
EvoCash launches a FinCEN-registered Web3 wallet-to-USD bridge, enabling real-time conversion and fiat access for a g...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
Retail investors on Reddit have shifted to a cautious stance on Tesla as late-2025 results reveal delivery declines a...
Stocks with dividends are drawing buyers as growth slows. HDV and SPYD command big flows, yet risk signals suggest on...
A new wave of investors is changing how rental markets work. Out-of-town buyers are driving rental demand in many top...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...